Contraceptive use in adolescents with perinatally and behaviorally acquired human immunodeficiency virus infection seen in a public Los Angeles county clinic

Jessica M. Atrio, Kyle Graham, Hita Vora, Eva Operskalski, Andrea Kovacs

Research output: Contribution to journalArticle

Abstract

Objective: Primary aim is to compare contraception practices between adolescent females aged 15-25 years with perinatally vs. behaviorally acquired HIV infection Design: A retrospective, pilot, chart review of 33 HIV positive adolescent females 15-25 years old, with one or more clinic visits at the Maternal Child and Adolescent Center for Infectious Diseases and Virology from January 1, 2010 to December 31, 2012 was conducted. Secondary outcomes included number of pregnancies, changes in contraceptive method, and condom use. Adolescents with perinatally and behaviorally acquired HIV infection were compared; and both groups were compared to the United States Centers for Disease Control national statistics. Results: Eighteen (55%) perinatally and 15 (45%) behaviorally HIV infected adolescents were studied. Depo medroxyporgesterone Acetate (DMPA) was the most commonly used contraceptive by the perinatal group (n=7, 39%) and the second most common method in the behaviorally infected group (n=4, 27%). Condoms were the second most commonly used method among perinatally infected adolescents (n=4, 22%). Condoms in addition to a hormonal contraceptive was used by 5 (28%) perinatal and 5 (33%) of the behavioral adolescents. None of the behavioral group used condoms as the exclusive method of contraception. Long Acting Reversible Contraception (LARC) was the most commonly used method by the behavioral group (n=5, 33%). The average number of pregnancies was 2.8 (range 1-5) among adolescents with behaviorally acquired HIV and. 0.4 (range 0-2) among adolescents with perinatally acquired infection (P<0.001). Conclusion: In this small pilot study, perinatally infected adolescents were more likely to use DMPA or condoms as compared to behaviorally infected adolescents, who were more likely to use LARC or DMPA though these differences were not statistically significant given the small sample size. Future larger studies should explore pregnancy and contraception in these distinct populations.

Original languageEnglish (US)
Article number1000244
JournalJournal of AIDS and Clinical Research
Volume4
Issue number10
DOIs
StatePublished - Oct 2013
Externally publishedYes

Fingerprint

Los Angeles
Virus Diseases
Contraceptive Agents
HIV
Contraception
Condoms
Acetates
Pregnancy
HIV Infections
Virology
Centers for Disease Control and Prevention (U.S.)
Ambulatory Care
Sample Size
Communicable Diseases
Mothers

Keywords

  • Adolescents
  • AIDS
  • Contraception
  • Family planning
  • Girls
  • Gravity
  • Heterosexual infection
  • HIV
  • Parity
  • Perinatal infection
  • Teen pregnancy
  • Women

ASJC Scopus subject areas

  • Infectious Diseases
  • Dermatology
  • Immunology
  • Virology

Cite this

Contraceptive use in adolescents with perinatally and behaviorally acquired human immunodeficiency virus infection seen in a public Los Angeles county clinic. / Atrio, Jessica M.; Graham, Kyle; Vora, Hita; Operskalski, Eva; Kovacs, Andrea.

In: Journal of AIDS and Clinical Research, Vol. 4, No. 10, 1000244, 10.2013.

Research output: Contribution to journalArticle

@article{63c6ad44764846b28175b02bcf430f16,
title = "Contraceptive use in adolescents with perinatally and behaviorally acquired human immunodeficiency virus infection seen in a public Los Angeles county clinic",
abstract = "Objective: Primary aim is to compare contraception practices between adolescent females aged 15-25 years with perinatally vs. behaviorally acquired HIV infection Design: A retrospective, pilot, chart review of 33 HIV positive adolescent females 15-25 years old, with one or more clinic visits at the Maternal Child and Adolescent Center for Infectious Diseases and Virology from January 1, 2010 to December 31, 2012 was conducted. Secondary outcomes included number of pregnancies, changes in contraceptive method, and condom use. Adolescents with perinatally and behaviorally acquired HIV infection were compared; and both groups were compared to the United States Centers for Disease Control national statistics. Results: Eighteen (55{\%}) perinatally and 15 (45{\%}) behaviorally HIV infected adolescents were studied. Depo medroxyporgesterone Acetate (DMPA) was the most commonly used contraceptive by the perinatal group (n=7, 39{\%}) and the second most common method in the behaviorally infected group (n=4, 27{\%}). Condoms were the second most commonly used method among perinatally infected adolescents (n=4, 22{\%}). Condoms in addition to a hormonal contraceptive was used by 5 (28{\%}) perinatal and 5 (33{\%}) of the behavioral adolescents. None of the behavioral group used condoms as the exclusive method of contraception. Long Acting Reversible Contraception (LARC) was the most commonly used method by the behavioral group (n=5, 33{\%}). The average number of pregnancies was 2.8 (range 1-5) among adolescents with behaviorally acquired HIV and. 0.4 (range 0-2) among adolescents with perinatally acquired infection (P<0.001). Conclusion: In this small pilot study, perinatally infected adolescents were more likely to use DMPA or condoms as compared to behaviorally infected adolescents, who were more likely to use LARC or DMPA though these differences were not statistically significant given the small sample size. Future larger studies should explore pregnancy and contraception in these distinct populations.",
keywords = "Adolescents, AIDS, Contraception, Family planning, Girls, Gravity, Heterosexual infection, HIV, Parity, Perinatal infection, Teen pregnancy, Women",
author = "Atrio, {Jessica M.} and Kyle Graham and Hita Vora and Eva Operskalski and Andrea Kovacs",
year = "2013",
month = "10",
doi = "10.4172/2155-6113.1000244",
language = "English (US)",
volume = "4",
journal = "Journal of AIDS and Clinical Research",
issn = "2155-6113",
publisher = "OMICS Publishing Group",
number = "10",

}

TY - JOUR

T1 - Contraceptive use in adolescents with perinatally and behaviorally acquired human immunodeficiency virus infection seen in a public Los Angeles county clinic

AU - Atrio, Jessica M.

AU - Graham, Kyle

AU - Vora, Hita

AU - Operskalski, Eva

AU - Kovacs, Andrea

PY - 2013/10

Y1 - 2013/10

N2 - Objective: Primary aim is to compare contraception practices between adolescent females aged 15-25 years with perinatally vs. behaviorally acquired HIV infection Design: A retrospective, pilot, chart review of 33 HIV positive adolescent females 15-25 years old, with one or more clinic visits at the Maternal Child and Adolescent Center for Infectious Diseases and Virology from January 1, 2010 to December 31, 2012 was conducted. Secondary outcomes included number of pregnancies, changes in contraceptive method, and condom use. Adolescents with perinatally and behaviorally acquired HIV infection were compared; and both groups were compared to the United States Centers for Disease Control national statistics. Results: Eighteen (55%) perinatally and 15 (45%) behaviorally HIV infected adolescents were studied. Depo medroxyporgesterone Acetate (DMPA) was the most commonly used contraceptive by the perinatal group (n=7, 39%) and the second most common method in the behaviorally infected group (n=4, 27%). Condoms were the second most commonly used method among perinatally infected adolescents (n=4, 22%). Condoms in addition to a hormonal contraceptive was used by 5 (28%) perinatal and 5 (33%) of the behavioral adolescents. None of the behavioral group used condoms as the exclusive method of contraception. Long Acting Reversible Contraception (LARC) was the most commonly used method by the behavioral group (n=5, 33%). The average number of pregnancies was 2.8 (range 1-5) among adolescents with behaviorally acquired HIV and. 0.4 (range 0-2) among adolescents with perinatally acquired infection (P<0.001). Conclusion: In this small pilot study, perinatally infected adolescents were more likely to use DMPA or condoms as compared to behaviorally infected adolescents, who were more likely to use LARC or DMPA though these differences were not statistically significant given the small sample size. Future larger studies should explore pregnancy and contraception in these distinct populations.

AB - Objective: Primary aim is to compare contraception practices between adolescent females aged 15-25 years with perinatally vs. behaviorally acquired HIV infection Design: A retrospective, pilot, chart review of 33 HIV positive adolescent females 15-25 years old, with one or more clinic visits at the Maternal Child and Adolescent Center for Infectious Diseases and Virology from January 1, 2010 to December 31, 2012 was conducted. Secondary outcomes included number of pregnancies, changes in contraceptive method, and condom use. Adolescents with perinatally and behaviorally acquired HIV infection were compared; and both groups were compared to the United States Centers for Disease Control national statistics. Results: Eighteen (55%) perinatally and 15 (45%) behaviorally HIV infected adolescents were studied. Depo medroxyporgesterone Acetate (DMPA) was the most commonly used contraceptive by the perinatal group (n=7, 39%) and the second most common method in the behaviorally infected group (n=4, 27%). Condoms were the second most commonly used method among perinatally infected adolescents (n=4, 22%). Condoms in addition to a hormonal contraceptive was used by 5 (28%) perinatal and 5 (33%) of the behavioral adolescents. None of the behavioral group used condoms as the exclusive method of contraception. Long Acting Reversible Contraception (LARC) was the most commonly used method by the behavioral group (n=5, 33%). The average number of pregnancies was 2.8 (range 1-5) among adolescents with behaviorally acquired HIV and. 0.4 (range 0-2) among adolescents with perinatally acquired infection (P<0.001). Conclusion: In this small pilot study, perinatally infected adolescents were more likely to use DMPA or condoms as compared to behaviorally infected adolescents, who were more likely to use LARC or DMPA though these differences were not statistically significant given the small sample size. Future larger studies should explore pregnancy and contraception in these distinct populations.

KW - Adolescents

KW - AIDS

KW - Contraception

KW - Family planning

KW - Girls

KW - Gravity

KW - Heterosexual infection

KW - HIV

KW - Parity

KW - Perinatal infection

KW - Teen pregnancy

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=84887585333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887585333&partnerID=8YFLogxK

U2 - 10.4172/2155-6113.1000244

DO - 10.4172/2155-6113.1000244

M3 - Article

AN - SCOPUS:84887585333

VL - 4

JO - Journal of AIDS and Clinical Research

JF - Journal of AIDS and Clinical Research

SN - 2155-6113

IS - 10

M1 - 1000244

ER -